-
公开(公告)号:US20210161908A1
公开(公告)日:2021-06-03
申请号:US17047436
申请日:2019-04-18
申请人: NATIONAL UNIVERSITY CORPORATION TOKYO UNIVERSITY OF AGRICULTURE AND TECHNOLOGY , TAIHO PHARMACEUTICAL CO., LTD.
发明人: Masaki INADA , Daisuke KAJIWARA
IPC分类号: A61K31/5377
摘要: This invention relates to a preventive and/or therapeutic agent for sarcopenia, comprising a prostaglandin D2 production inhibitor as an active ingredient.
-
公开(公告)号:US20150164879A1
公开(公告)日:2015-06-18
申请号:US14041222
申请日:2013-09-30
发明人: Chisato MIYAURA , Masaki INADA , Hidenori FUJITA
IPC分类号: A61K31/47
CPC分类号: A61K31/47
摘要: To provide an agent for treating osteoporosis, comprising an acyl thiourea compound represented by the following formula (I) or a salt thereof as an active ingredient: wherein, R1 represents an optionally substituted C1-6 alkyl group; R2 represents a fluorine atom or a chlorine atom; and R3 represents a hydrogen atom, a fluorine atom, or a chlorine atom.
摘要翻译: 提供一种治疗骨质疏松症的药剂,其包含由下式(I)表示的酰基硫脲化合物或其盐作为活性成分:其中,R 1表示任选取代的C 1-6烷基; R2表示氟原子或氯原子; R3表示氢原子,氟原子或氯原子。
-